Eleclazine, identified by the CAS number 1443211-72-0, is a chemical compound that has garnered attention in pharmaceutical research, particularly for its potential therapeutic applications. It is characterized by its unique molecular structure, which contributes to its biological activity. Eleclazine is primarily studied for its effects on the cardiovascular system, specifically as an antiarrhythmic agent. Its mechanism of action involves modulation of ion channels, which plays a crucial role in cardiac electrical activity. The compound exhibits a favorable pharmacokinetic profile, including absorption, distribution, metabolism, and excretion characteristics that support its efficacy and safety in clinical settings. Additionally, ongoing research is focused on understanding its interactions with other drugs and its long-term effects on patients. As with many pharmaceutical compounds, the specific characteristics, including solubility, stability, and reactivity, are critical for its formulation and therapeutic use. Overall, Eleclazine represents a promising candidate in the field of cardiology, with ongoing studies aimed at elucidating its full potential.

Eleclazine

Find at CymitQuimica all products linked to CAS 1443211-72-0. Enter now to get more information

1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl]-

4-(Pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one

Eleclazine is a pharmaceutical drug that is used to treat a variety of diseases. It mainly affects the heart by increasing the intracellular calcium concentration, which leads to an increase in cardiac contractility. Eleclazine has also been shown to be effective against cancer cells and can be used as a diagnostic agent for identifying cancerous cells. Eleclazine is activated by esterases and hydrolyzes into atrial natriuretic peptide (ANP). Eleclazine inhibits the Na channel and prevents electrical currents from passing through it, preventing the generation of action potentials. This results in potent inhibition of neuronal activity.

eleclazine

Eleclazine (GS-6615) is a late sodium current inhibitor for treating LQT3 syndrome and arrhythmias, shortens QTc interval.

CAS 1443211-72-0: Eleclazine

1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl]-

Ref: IN-DA001JBG

4-(Pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one

Ref: 10-F547024

eleclazine

Ref: 3D-THC21172

Eleclazine free base

Ref: TM-T71945

Eleclazine

Ref: TR-E975168